Rennova Health, Inc. - stock earnings
RNVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | 805560 USD | 4.9 million USD |
| 2022Q4 | 819858 USD | ? USD |
| 2022Q3 | -1.3 million USD | 2.8 million USD |
| 2022Q2 | -503786 USD | 3.6 million USD |
| 2022Q1 | -2.3 million USD | 1.1 million USD |
| 2021Q4 | -903131 USD | 1.9 million USD |
| 2021Q3 | 1.3 million USD | 1.0 million USD |
| 2021Q2 | 9.1 million USD | 928849 USD |
RNVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -3.3 million USD | 13.0 million USD |
| 2021 | 5.6 million USD | 3.2 million USD |
| 2020 | -18.3 million USD | 7.2 million USD |
| 2019 | -48.0 million USD | 16.0 million USD |
| 2018 | -14.0 million USD | 14.5 million USD |
RNVA
Price: $0
52 week price:
Earnings Per Share: 0.05 USD
P/E Ratio: 0.00
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 4.9 million
Ebitda: -27.3 millionMarket Capitalization: 4.1 million